I agree, the FDA, BAT, X22 could be huge bonuses to the main business and that business should start growing revenues starting in the first quarter. Management has a ton of experience in this field and have many connections worldwide to make this very successful.
Red Sun and Magic cigarettes sales in the states and VLN cigarettes overseas could become a multi billion dollar business on its own. This is the reason I'm invested because this takes the risk of the FDA, BAT and finding a partner for X22. The potential revenues just for Red Sun, Magic and VLN would make us shareholders large profits and potential dividends down the road.
If one of the above come to fruition then the added bonus would be massive but I don't see much risk waiting for that to happen, the numbers below prove you only have to capture a very small percentage of the markets to make a lot of money.
Super premium cigarettes (Red Sun® and Magic®) …just 1% of the premium U.S. market is valued more than $1B – Lorillard (NYSE: LO) only sells cigarettes in the U.S.; has 14% market share and $15B market cap
Market Data 
Markets 
